Exactus (OTCMKTS:EXDI) and Babcock & Wilcox Enterprises (NYSE:BW) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings.
This is a breakdown of recent ratings and recommmendations for Exactus and Babcock & Wilcox Enterprises, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Babcock & Wilcox Enterprises||1||0||0||0||1.00|
Babcock & Wilcox Enterprises has a consensus price target of $3.50, suggesting a potential upside of 316.67%. Given Babcock & Wilcox Enterprises’ higher possible upside, analysts plainly believe Babcock & Wilcox Enterprises is more favorable than Exactus.
Institutional & Insider Ownership
63.8% of Babcock & Wilcox Enterprises shares are held by institutional investors. 52.9% of Exactus shares are held by company insiders. Comparatively, 3.6% of Babcock & Wilcox Enterprises shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
Exactus has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, Babcock & Wilcox Enterprises has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500.
Valuation & Earnings
This table compares Exactus and Babcock & Wilcox Enterprises’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Babcock & Wilcox Enterprises||$1.56 billion||0.09||-$379.82 million||N/A||N/A|
Exactus has higher earnings, but lower revenue than Babcock & Wilcox Enterprises.
This table compares Exactus and Babcock & Wilcox Enterprises’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Babcock & Wilcox Enterprises||-45.90%||-457.13%||-26.42%|
Babcock & Wilcox Enterprises beats Exactus on 5 of the 9 factors compared between the two stocks.
Exactus Company Profile
Exactus, Inc. is a life science company, which engages in developing and commercializing Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a novel detection platform. It operates under the FibriLyzer and MatriLyzer trademarks. The company was founded on January 18, 2008 and is headquartered in Glen Allen, VA.
Babcock & Wilcox Enterprises Company Profile
Babcock & Wilcox Enterprises, Inc. provides fossil and renewable power generation and environmental equipment for the power and industrial markets worldwide. Its Power segment offers boiler cleaning and material handling equipment; and supercritical, subcritical, fluidized bed, chemical recovery, industrial power, package, and waste heat boilers, as well as heat recovery steam generators. It also provides air pollution control products and related equipment, such as wet and dry flue gas desulfurization systems, catalytic and non-catalytic nitrogen oxides reduction systems, low nitrogen oxides burners and overfire air systems, fabric filter baghouses, wet and dry electrostatic precipitators, mercury control systems, and dry sorbent injection for acid gas mitigation. In addition, this segment also offers replacement parts, retrofit and upgrade projects, fuel switching and repowering projects, and training programs; and field technical, construction and maintenance, start-up and commissioning, and plant operations and maintenance services. The company's Renewable segment provides steam-generating systems; environmental and auxiliary equipment for the waste-to-energy and biomass power generation industries; and plant operations and maintenance services. Its Industrial segment offers oxidizers, solvent recovery and distillation systems, wet electrostatic precipitators, scrubbers, and heat recovery systems; and specialized industrial process systems, coating lines, and equipment. This segment also provides air-cooled (dry) cooling systems, mechanical draft wet cooling towers, and natural draft wet cooling hyperbolic towers; end-to-end aftermarket services, such as spare parts, upgrades and revamping of existing installations, and remote monitoring; and gas turbine inlet and exhaust systems, custom silencers, and filters and enclosures. The company was founded in 1867 and is headquartered in Charlotte, North Carolina.
Receive News & Ratings for Exactus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactus and related companies with MarketBeat.com's FREE daily email newsletter.